{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T10:25:07Z","timestamp":1772360707748,"version":"3.50.1"},"reference-count":5,"publisher":"SCEEMP","issue":"4","license":[{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.vedomostincesmp.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.vedomostincesmp.ru"],"crossmark-restriction":true},"short-container-title":["Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya"],"DOI":"10.30895\/1991-2919-2022-423","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T10:50:13Z","timestamp":1651834213000},"page":"364-378","update-policy":"https:\/\/doi.org\/10.30895\/1991-2919-crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Radioisotope Products and the Medicine of the Future: an IAEA Perspective"],"prefix":"10.30895","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1948-0580","authenticated-orcid":true,"given":"A.","family":"Jalilian","sequence":"first","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9539-5521","authenticated-orcid":true,"given":"A.","family":"Korde","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-1853","authenticated-orcid":true,"given":"V.","family":"Starovoitova","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6672-1631","authenticated-orcid":true,"given":"J. Jr.","family":"Osso","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-0455","authenticated-orcid":true,"given":"A.","family":"Koning","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-8573","authenticated-orcid":true,"given":"N.","family":"Pessoa Barradas","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4130-0395","authenticated-orcid":true,"given":"C.","family":"Horak","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0210-1844","authenticated-orcid":true,"given":"M.","family":"Denecke","sequence":"additional","affiliation":[{"name":"Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna International Centre"}]}],"member":"12343","published-online":{"date-parts":[[2022,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, et al. Production and supply of \u03b1-particle-emitting radionuclides for targeted \u03b1-therapy. J Nucl Med. 2021;62(11):1495\u2013503. https:\/\/doi.org\/10.2967\/jnumed.120.261016","DOI":"10.2967\/jnumed.120.261016"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193\u20139. https:\/\/doi.org\/10.7150\/ijms.3635","DOI":"10.7150\/ijms.3635"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jalilian AR, Osso JA. Production, applications and status of zirconium-89 immunoPET agents. J Radioanal Nucl Chem. 2017;314:7\u201321. https:\/\/doi.org\/10.1007\/s10967-017-5358-z","DOI":"10.1007\/s10967-017-5358-z"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Jalilian AR, Gizawy MA, Alliot C, Takacs S, Chakarborty S, Rovais MRA, et al. IAEA activities on 67Cu, 186Re, 47 Sc theranostic radionuclides and radiopharmaceuticals. Curr Radiopharm. 2021;14(4):306\u201314. https:\/\/doi.org\/10.2174\/1874471013999200928162322","DOI":"10.2174\/1874471013999200928162322"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Jalilian AR, Osso Jr JA, Vera-Araujo J, Kumar V, Harris MJ, Gutfilen B, et al. IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications. Q J Nucl Med Mol Imaging. 2020;64(4):338\u201345. https:\/\/doi.org\/10.23736\/s1824-4785.20.03302-6","DOI":"10.23736\/S1824-4785.20.03302-6"}],"container-title":["The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation"],"original-title":[],"link":[{"URL":"https:\/\/www.vedomostincesmp.ru\/jour\/article\/viewFile\/423\/650","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T21:11:53Z","timestamp":1670015513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.vedomostincesmp.ru\/jour\/article\/view\/423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":5,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12,2]]}},"URL":"https:\/\/doi.org\/10.30895\/1991-2919-2022-423","relation":{},"ISSN":["2619-1172","1991-2919"],"issn-type":[{"value":"2619-1172","type":"electronic"},{"value":"1991-2919","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,30]]}}}